IXHLNasdaqPharmaceutical PreparationsFiscal year ends June 30
Incannex Healthcare Inc.
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 25, 2026
$2.76−0.06 (-2.13%)
Close on Oct 19, 2026
- Market cap
- $33.89M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$7.69 (−73.60%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
Incannex Healthcare Inc. saw revenue fall 100.0% to $0 over fiscal 2026. Free cash flow was -$12.88M.
Revenue
$0
-100.0% vs. a year earlier
Operating income
-$23.03M
TTM Q4 2026
Free cash flow
-$12.88M
TTM Q4 2026
EPS, diluted
-$1.66
TTM Q4 2026
Key statistics
Valuation at the latest close; fundamentals over fiscal 2026, balances at Jun 30, 2026
Valuation
- Market cap
- $33.89M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.50
- Dividend yield
- –
- Free cash flow yield
- -37.99%
Fundamentals
- Revenue
- $0
- Net income
- -$19.30M
- EPS, diluted
- -$1.66
- Free cash flow
- -$12.88M
- Book value per share
- $5.49
- Diluted shares
- 12M
Seven years at a glance
Fiscal years 2020 to 2026, USD
Revenue
$0-100.0% YoY
Gross profit
–
Operating income
-$23.03M
Net income
-$19.30M
EPS, diluted
-$1.66
Free cash flow
-$12.88M
Reported period